STAR Medicaid Pharmacy & Drugs

FirstCare STAR members can access prescriptions through any pharmacy that is contracted with Navitus Health Solutions. Navitus administers prescription benefits for FirstCare STAR Members. For pharmacy questions, contact Customer Service at 1-877-639-2447.

You can view your pharmacy directory using the links below:

Formulary

FirstCare uses the state mandated STAR formulary. The formulary is available on the Texas Medicaid Drug Vendor Drug Program website.

The Texas STAR Formulary is available in paper form without charge. To request a copy, please call FirstCare STAR Customer Service at 1-800-431-7798.

Prior Authorizations

To obtain a prior authorization, providers should call Navitus at 1-877-908-6023. For a listing of clinical edits implemented by FirstCare please click here, and for access to FirstCare's prior authorization forms please click here.
  • Download the State of Texas Standard Prior Authorization Form.
  • If your doctor cannot be reached to approve a prescription, you can get a three-day emergency supply of your medication. Call FirstCare at 1-806-784-4300 for help with your medications and refills.

Member Forms

Prescription Mail Order Form
Prescription Mail Order Form (Spanish)

News

Change in Preferred Drug List Status for the Smoking Cessation Drug Class Effective May 16, 2023 For additional information, click here.

HHSC to Implement Clinical Prior Authorization for Gattex on June 6, 2023 For additional information, click here.

HHSC to Implement Clinical Prior Authorization for Antimigraine Agents-Ergot Derivatives on June 6, 2023 For additional information, click here.

Members Sought for the Drug Utilization Review Board For additional information, click here.

HHSC to Revise Qulipta Criteria for Clinical Prior Authorization on June 27, 2023 For additional information, click here.

HHSC to Implement Sotyktu Criteria in Cytokine and CAM Antagonists Clinical Prior Authorization on July 27, 2023 For additional information, click here.

HHSC to Implement Pulmonary Hypertension Agents Clinical Prior Authorization on July 27, 2023 For additional information, click here.

Preferred Mavyret for Hepatitis C Infection Treatment and Change to Quantity Limit for Hepatitis C Medications

HHSC Removed Monovalent Moderna and Pfizer-BioNTech COVID-19 Vaccines From Formulary on April 21, 2023 For additional information, click here.

HHSC to Update Hereditary Angioedema Clinical Prior Authorization For Fee-For-Service on May 23, 2023 For additional information, click here.

HHSC to Update Anxiolytics and Sedative-Hypnotics Clinical Prior Authorization For Fee-For-Service on June 22, 2023 For additional information, click here.

Jan. 2023 Preferred Drug List Decisions Now Available For additional information, click here.

Update to "HHSC To Implement Clinical Prior Authorizations For Fee-For-Service" For additional information, click here.

Pharmacy Email Addresses Must Be Current in PEMS For additional information, click here.

Clinical Prior Authorization Assistance Chart Now Available For additional information, click here.

Memorial Day Holiday to Delay Pharmacy Payments For additional information, click here.

HHSC to Revise Opiate/Benzodiazepine/Muscle Relaxant Combinations Prior Authorization For additional information, click here.

Summary of April 2023 Drug Utilization Review Board Meeting Now Available For additional information, click here.

HHSC To Update Opioid Product Information in Clinical Prior Authorizations for Medicaid Fee-for-Service For additional information, click here.

April 2023 NDC-to-HCPCS Crosswalk Now Available For additional information, click here.

Revised VDP Manuals Available For additional information, click here.

CSHCN Removes Remodulin From Formulary As Of April 17, 2023 For additional information, click here.

CSHCN To Remove Multiple Drugs From Formulary on June 1, 2023 For additional information, click here.

Age Expansion Indication for Cibinqo Clinical Prior Authorization Criteria Effective May 31, 2023 For additional information, click here.

Update to Livmarli Clinical Prior Authorization Criteria Effective May 30, 2023 For additional information, click here.

Makena Products No Longer Covered As Of April 7, 2023 For additional information, click here.

Agenda for April Drug Utilization Review Board Meeting Now Available For additional information, click here.

Texas State Plan Public Notice of Intent for Waiver of Drug Counseling Signature Requirements For additional information, click here.

March 2023 Specialty Drug List AvailableFor additional information, click here.

Hereditary Angioedema Agents Clinical Prior Authorization Effective for Medicaid Fee-for-Service on April 11, 2023For additional information, click here.

HHSC to Implement Enzymes Clinical Prior Authorization for Medicaid Fee-for-Service on April 18, 2023For additional information, click here.

Temporary Change in PDL Status for the Neuropathic Pain Drug Class Effective April 3, 2023For additional information, click here.

Pharmacy Education Information and OpportunitiesFor additional information, click here.

Revisions of Antimigraine Agents (Triptans) Clinical Prior Authorization Criteria Scheduled for April 5, 2023 (Revised) For additional information, click here.

Implementation of Inhaled Antibiotics Clinical Prior Authorization for Medicaid Fee-For-Service Set for May 2, 2023 For additional information, click here.

HHSC To Implement Multiple Clinical Prior Authorizations For Fee-For-Service For additional information, click here.

Pharmacy Resolution Help Desk Down Due To Statewide Outages For additional information, click here.

Extended Database Maintenance For Pharmacy Claims Vendor Weekend of March 18, 2023  For additional information, click here.

Draft Specialty Drug List Available for Comment, Responses Due March 17, 2023   For additional information, click here.

Clinical Prior Authorization Criteria for Calcitonin Gene-Related Peptide Receptor Antagonists Effective April 4, 2023  For additional information, click here.

Revised VDP Manuals Available  For additional information, click here.

Revision of Olumiant Clinical Prior Authorization Criteria Scheduled for March 27, 2023  For additional information, click here.

Revisions of Antimigraine Agents (Triptans) Clinical Prior Authorization Criteria Scheduled for April 4, 2023  For additional information, click here.

Respiratory Syncytial Virus (RSV) Season Ends on March 1, 2023   For additional information, click here.

2022-23 RSV Season Schedule   For additional information, click here.

January 2023 Drug Utilization Review Board Meeting  For additional information, click here.

Clinical Prior Authorization Assistance Chart Now Available  For additional information, click here.

January 2023 Preferred Drug List Updated   For additional information, click here.

Changes to Lovaza Clinical Prior Authorization Scheduled for March 21, 2023   For additional information, click here.

January 2023 NDC-to-HCPCS Crosswalk Now Available   For additional information, click here.

Changes in Hepatitis C Treatment Coverage for Medicaid Clients Begins Jan. 1, 2023    For additional information, click here.

Clinical Prior Authorization Criteria Changes Scheduled for Feb. 7, 2023   For additional information, click here.

Androgenic Agents Clinical Prior Authorization Criteria Revision Scheduled for Feb. 1, 2023   For additional information, click here.

Younger Age Groups Now Eligible For Updated Bivalent COVID-19 Vaccines    For additional information, click here.

July 2022 Preferred Drug List Updated   For additional information, click here.

Pharmacy Education Information and Opportunities   For additional information, click here.

NDC Requirements for the Submission of Clinician-Administered Drug Claims   For additional information, click here.

Revised VDP Manuals Available   For additional information, click here.

Agenda for January Drug Utilization Review Board Meeting Now Available   For additional information, click here.

Retroactive Claim Form Process Ending Dec. 31, 2022   For additional information, click here.

Revised VDP Manuals Available   For additional information, click here.

Clinical Prior Authorization for Calcitonin Gene-Related Peptide Receptor (CGRP) Antagonists in Traditional Medicaid Begins Dec. 30, 2022   For additional information, click here.

Genabio COVID-19 At-Home Test Kit Added to Formulary   For additional information, click here.

Semi-annual Medicaid Preferred Drug List Update Coming Jan. 26, 2023   For additional information, click here.

Hepatitis C Treatment Coverage and PDL Update Scheduled for Jan. 1, 2023   For additional information, click here.

Manufacturer Reminder For Properly Submitting Rebate Invoices   For additional information, click here.

Clinical Prior Authorization Assistance Chart Now Available   For additional information, click here.

Input on Proposed Medicaid, CHIP Formulary, PDL and Prior Authorization Management Transition Policy Due Dec. 4, 2022   For additional information, click here.

Revised VDP Manuals Available   For additional information, click here.

October 2022 Drug Utilization Review Board Meeting Summary   For additional information, click here.

New Report from HHSC   For additional information, click here.

CGRP Antagonist Prophylaxis Prior Authorization Revisions Scheduled for Nov. 22, 2022   For additional information, click here.

Revision to Cosentyx Clinical Prior Authorization Criteria Scheduled for Nov. 22, 2022   For additional information, click here.

October 2022 NDC-to-HCPCS Crosswalk Now Available   For additional information, click here.

Clinical Prior Authorization Criteria Revisions for Bylvay Scheduled for Nov. 21, 2022   For additional information, click here.

July 2022 Preferred Drug List Decisions Now Available   For additional information, click here.

Clinical Criteria Update for Orkambi Scheduled for Nov. 9, 2022   For additional information, click here.

Summer 2022 RSV Season Schedule   For additional information, click here.

RSV Fall/Winter Traditional Season Regional Changes Effective Oct. 17, 2022   For additional information, click here.

2022-23 RSV Season Schedule   For additional information, click here.

ProAir HFA Inhaler Discontinuation   For additional information, click here.

Revised VDP Manuals Available   For additional information, click here.

Pharmacy Education Reminder   For additional information, click here.

Agenda for October Drug Utilization Review Board Meeting Now Available   For additional information, click here.

PDL Prior Authorization Criteria Revisions Scheduled For Oct. 11, 2022   For additional information, click here.

Criteria Changes for Subsequent Dosing of Palivizumab (Synagis) with Fall/Winter Traditional Respiratory Syncytial Virus Season   For additional information, click here.

Temporary Change in PDL Status for Clonidine Transdermal Patches Effective Sept. 26, 2022   For additional information, click here.

Clinical Prior Authorization Criteria Revisions Implement for Medicaid Fee-for-Service On Oct. 26, 2022   For additional information, click here.

September 2022 Specialty Drug List Available   For additional information, click here.

Pharmacy Prior Authorization System Maintenance Scheduled for Monday, Oct. 3, 2022   For additional information, click here.

Psychiatrist Sought for the Drug Utilization Review Board   For additional information click here.

Bivalent Moderna COVID-19 Booster Vaccine Coverage Update   For additional information click here.

Bivalent Pfizer COVID-19 Booster Vaccine Coverage Update   For additional information, click here.

Hepatitis C Treatment Coverage and PDL Update Scheduled for Jan. 1, 2023   For additional information, click here.

RSV Summer Season Changes Begin Sept. 1, 2022   For additional information, click here.

Draft Specialty Drug List Available for Comment, Responses Due Sept. 22, 2022   For additional information, click here.

July 2022 Preferred Drug List Updated   For additional information, click here.

Drug Regimen Optimization Clinical Prior Authorization to Retire Sept. 12, 2022   For additional information click here.

Clinical Prior Authorization Assistance Chart Now Available   For additional information, click here.

Clinical Prior Authorization for Xenical No Longer Required After Sept. 12, 2022   For additional information, click here.

Hepatitis C Treatment Coverage and PDL Update Scheduled for Sept. 1, 2022   For additional information, click here.

July 2022 Preferred Drug List Now Available   For additional information click here.

Revised VDP Manuals Available   For additional information click here.

July 2022 Drug Utilization Review Board Meeting Summary   For additional information click here.

EXTENDED: Members Sought for the Drug Utilization Review Board until Aug. 1, 2022   For additional information click here.

July 2022 NDC-to-HCPCS Crosswalk Now Available   For additional information click here.

Novavax COVID-19 Vaccine Coverage Update   For additional information click here.

Prior Authorization Criteria Update for Rinvoq and Cibinqo   For additional information click here.

Semi-annual Medicaid Preferred Drug List Update Coming July 28, 2022    For additional information click here.

April 2022 Preferred Drug List Decisions Now Available   For additional information click here.

Revised Application for Texas Identification Number Now Available for Pharmacy Enrollment   For additional information click here.

HHSC Pharmacy Prior Authorization System Maintenance Scheduled for Early Morning This Wednesday   For additional information click here.

HHSC to Reject Pharmacy Claims for Inaccurate License Information Beginning Sept. 28, 2022   For additional information click here.

Agenda for July Drug Utilization Review Board Meeting Now Available   For additional information click here.

Revised VDP Manuals Available   For additional information click here.

Clinical Prior Authorization Criteria Updates for Dupixent, Evrysdi, and Qelbree   For additional information click here.

Pediatric Updates for Moderna & Pfizer-BioNTech COVID-19 Vaccines   For additional information click here.

Medicare Part B and D Indicators Available on Formulary Searches Beginning June 6, 2022   For additional information click here.

EXTENDED: Members Sought for the Drug Utilization Review Board until July 1, 2022   For additional information click here.

COVID-19 Drug Veklury (Remdesivir) Update   For additional information, click here.

Clinical Prior Authorization Assistance Chart Now Available   For additional information, click here.

Summer 2022 RSV Season Schedule   For additional information, click here.

Pfizer COVID-19 Vaccine Booster Dose for Children Update   For additional information, click here.

Moderna COVID-19 Vaccine Booster Dose Update   For additional information, click here.

Respiratory Syncytial Virus (RSV) Prophylaxis Season Reopening Across All Regions   For additional information, click here.

Changes for Client Access to Mosquito Repellent Benefit Begin June 1, 2022   For additional information, click here.

Spikevax COVID-19 Vaccine Coverage Update   For additional information, click here.

Members Sought for the Drug Utilization Review Board  For additional information click here.

Changes for Client Access to Mosquito Repellent Benefit Begin June 1, 2022  For additional information click here.

Update to the Pharmacy Procedure Manual Now Available  For additional information click here.

Second COVID-19 Vaccine Booster Dose Update  For additional information click here.

Request for Pharmacies to Check That Pharmacy Licenses Are Current in PEMS  For additional information click here.

April 2022 Drug Utilization Review Board Meeting Summary  For additional information click here.

Revision to Makena Authorization Request Form Scheduled for June 10, 2022  For additional information click here.

January 2022 Preferred Drug List Decisions Now Available  For additional information click here.

Update to the Pharmacy Procedure Manual Now Available  For additional information click here.

March 2022 Specialty Drug List Available  For additional information click here.

Agenda for April Drug Utilization Review Board Meeting Now Available  For additional information click here.

Pharmacy Education Reminder  For additional information click here.

Changes for Client Access to Mosquito Repellent Benefit Begin June 1, 2022  For additional information click here.

Draft Specialty Drug List Available for Comment  For additional information click here.

Updates to Phosphate Binder Prior Authorization Criteria Scheduled for April 5, 2022  For additional information click here.

Cytokine and CAM Antagonists Criteria Updates Scheduled for April 5, 2022  For additional information click here.

Oxbryta Prior Authorization Criteria Updates Scheduled for April 5, 2022  For additional information click here.

January 2022 Drug Utilization Review Board Meeting Summary  For additional information click here.

Clinical Prior Authorization Assistance Chart Now Available  For additional information click here.

2021-22 Respiratory Syncytial Virus (RSV) Season Ends February 1, 2022  For additional information click here.

January 2022 Preferred Drug List Now Available  For additional information click here.

Temporary Change in PDL Status for Tetracyclines Drug Class, Effective January 11, 2022  For additional information click here.

Pfizer-BioNTech COVID-19 Booster Update  For additional information click here.

November 2021 Preferred Drug List Decisions Now Available  For additional information click here.

Pfizer-BioNTech COVID-19 Vaccine Booster Dose Age Change and New Formulation  For additional information click here.

Agenda for January Drug Utilization Review Board Meeting Now Available  For additional information click here.

Managed Care Resources Update  For additional information click here.

COVID-19 At-home Test Kits Available as a Pharmacy Benefit  For additional information click here.

Pfizer Oral COVID-19 Drug, Paxlovid, Added to Formulary  For additional information click here.

Medicaid Pharmacy Benefit Accredited Course, Quick Courses Available  For additional information click here.

You Can Report Drug Shortages to HHSC  For additional information click here.

Merck Oral COVID-19 drug, Molnupiravir, Added to Formulary  For additional information click here.

Change in Age Limit for Pharmacist-Administered Influenza Vaccines  For additional information click here.

Kidney Health Care Adds New Drugs to Formulary  For additional information click here.

COVID-19 Vaccine Booster Update  For additional information click here.

Semi-annual Medicaid Preferred Drug List Update Coming January 27, 2022  For additional information click here.

Draft of Medication Therapy Management Policy Available for Comment  For additional information click here.

Stimate Nasal Spray National Drug Shortage  For additional information click here.

Pharmacy Services Change of Ownership (CHOW) Interim Process  For additional information click here.

Promethazine Clinical Prior Authorization Criteria Updates Scheduled for December 7, 2021  For additional information click here.

Dupixent Clinical Prior Authorization Criteria Update Scheduled for January 4, 2022  For additional information click here.

Clinical Prior Authorization Assistance Chart Now Available  For additional information click here.

November 2021 Drug Utilization Review Board Meeting Summary  For additional information click here.

July 2021 Preferred Drug List Revised December 3, 2021  For additional information click here.

Removal of Specialist Requirement from Clinical Prior Authorization Criteria Scheduled for January 3, 2022  For additional information click here.

Agenda for November Drug Utilization Review Board Meeting Now Available  For additional information click here.

Order and Administration of Selected COVID-19 Monoclonal Antibody Therapeutics Reimbursable Through Medicaid Medical Claims System  For additional information click here.

COVID-19 Vaccine Coverage Update: Comirnaty and Pfizer Age Change  For additional information click here.

Removal of Specialist Requirement from Clinical Prior Authorization Criteria Scheduled for January 3, 2021  For additional information click here.

Coverage of COVID-19 Booster Doses of Moderna and Johnson & Johnson Vaccines  For additional information click here.

October 2021 NDC-to-HCPCS Crosswalk Now Available  For additional information click here.

Updates to Medicaid Preferred Drug List Scheduled for November 15, 2021  For additional information click here.

Pharmacy Submittal of COVID-19 Vaccine Additional, Booster Doses  For additional information click here.

Nucala Clinical Prior Authorization Update Scheduled for December 14, 2021   For additional information click here.

Repatha (evolocumab) Prior Authorization Update Scheduled for December 6, 2021  For additional information click here.

Hepatitis C Drug Rebate Program Procurement Information Now Available  For additional information click here.

HHSC Updates Respiratory Syncytial Virus (RSV) Season Schedule  For additional information click here.

HHSC Issues Stromectol (Ivermectin) Guidance  For additional information click here.

Temporary Change in Texas Pharmacy Prior Authorization Call Center Phone Number  For additional information click here.

Alinia Clinical Prior Authorization Criteria Revision Effective November 23, 2021   For additional information click here.

Updating Pharmacy Claim Systems for COVID-19 Vaccine Additional Doses  For additional information click here.

2021-22 RSV Assessment and Synagis Authorization  For additional information click here.

Changes to Hepatitis C Prior Authorization Criteria Begin September 1, 2021  For additional information click here.

Duplicate Therapy Clinical Prior Authorization Criteria Revision Begins October 19, 2021  For additional information click here.

Respiratory Syncytial Virus and Synagis Authorization During Summer and Winter 2021-2022  For additional information click here.

July 2021 Drug Utilization Review Board Meeting Summary  For additional information click here.

Atypical Respiratory Syncytial Virus (RSV) Season Advisory  For additional information click here.

April 2021 Preferred Drug List Decisions Now Available  For additional information click here.

July 2021 Preferred Drug List Now Available  For additional information click here.

Changes to Hepatitis C Prior Authorization Criteria Begin September 1, 2021  For additional information click here.

Trikafta Age Expansion in Cystic Fibrosis Agents Clinical Prior Authorization Begins September 1, 2021  For additional information click here.

Nucala Clinical Prior Authorization Criteria Update Begins July 12, 2021  For additional information click here.

Semi-annual Medicaid Preferred Drug List Update Coming July 29, 2021  For additional information click here.

HHSC to Reopen RSV Season in Select Regions on June 21, 2021  For additional information click here.

Medicaid Allows Pfizer BioNTech COVID-19 Vaccine for Emergency Use in Adolescents  For additional information click here.

HHSC to Resume Quarterly Specialty Drug List in July 2021  For additional information click here.

COVID-19 Testing in Pharmacy Reimbursable Through Medicaid Medical Claims System  For additional information click here.

Clinical Prior Authorization Assistance Chart Now Available  For additional information click here.

April 2021 Preferred Drug List Recommendations Now Available  For additional information click here.

COVID-19 Vaccine Administration Rate Change Effective April 1, 2021  For additional information click here.

January 2021 Preferred Drug List Decisions Now Available  For additional information click here.

Enzymes Clinical Prior Authorization Criteria Revisions Effective June 30, 2021  For additional information click here.

Frequently Asked Questions about the Medicaid Standing Order for Mosquito Repellent  For additional information click here.

Epidiolex Prior Authorization Revision Scheduled for May 11, 2021  For additional information click here.

Medicaid Adds Johnson & Johnson COVID-19 Vaccine to Formulary  For additional information click here.

Revised Hepatitis C Drug Prior Authorization Form 1342  For additional information click here.

January 2021 Preferred Drug List Revised March 5, 2021  For additional information click here.

Revisions to Cytokine and CAM Antagonists Prior Authorization Criteria Set for May 4, 2021  For additional information click here.

RSV Season Extended for Counties in Southeast Texas and Gulf Coast Areas  For additional information click here.

Monoclonal Antibody for Asthma Prior Authorization Updates Set for April 6, 2021  For additional information click here.

Revised Hepatitis C Drug Prior Authorization Forms Now Available  For additional information click here.

Clinical Prior Authorization Updates for Cystic Fibrosis Agents  For additional information click here.

Preferred Drug List Criteria Exception for Macrolides Changes March 15  For additional information click here.

Renewed Texas Standing Order for Mosquito Repellent Benefit Available  For additional information click here.

Clinical Prior Authorization Assistance Chart Now Available  For additional information click here.

January 2021 Preferred Drug List Now Available  For additional information click here.

Desmopressin Clinical Prior Authorization Revision Begins March 15, 2021  For additional information click here.

COVID-19 Vaccine NDC Update  For additional information click here.

Dupixent Clinical Prior Authorization Criteria Revision Effective March 15, 2021  For additional information click here.

Change to Thiazolidinediones Clinical Prior Authorization Begins February 4, 2021  For additional information click here.

Medicaid Adds Moderna COVID-19 Vaccine to Formulary  For additional information click here.

Medicaid Adds Pfizer BioNTech COVID-19 Vaccine to Formulary  For additional information click here.

July 2020 Preferred Drug List Revised Dec. 16  For additional information click here.
 

Semi-annual Medicaid Preferred Drug List Update Coming Jan. 28, 2021  Preferred drugs are medications recommended by the Texas Drug Utilization Review Board. The Texas Preferred Drug List is published every January and July. For additional information click here.

Member Portal

Log In/Register

Authorization Information

Click here to access authorization information.

Find a Provider

Click below for the STAR provider directories:

Access a Doctor, 24/7/365

FirstCare Virtual Care—powered by MDLIVE lets you connect with a doctor from wherever you are. Find out more here.

Need Help?
Contact Us!

Call FirstCare STAR Customer Service at 1-800-431-7798. 

We're open Monday through Friday, from 8 a.m. to 5 p.m., excluding state approved holidays. If you call after hours, please leave us a message. We return all calls the next business day.
 
Our Customer Service Representatives speak both English and Spanish. If you speak another language, we can connect you with an interpreter. You can get information in larger print, audio (CD), braille, or in any other language format, if needed. For help, call FirstCare STAR Customer Service at 1-800-431-7798.

Members with hearing loss can call the Relay Texas number 711. Relay Texas is a free telephone interpreting service to help people with hearing or speech disabilities.

Resources

STAR Medicaid Service Area STAR Member News

Talk to a Nurse—Nurse24™

Need care advice? Should you see a doctor? FirstCare members can talk to a nurse by calling 1-855-828-1013. Get answers 24 hours a day, 7 days a week! Information is available in English and Spanish. Interpreter services available upon request. TTY users can call 711 or 1-800-955-8771. Voice communication is available at 1-800-955-8770.

Utilization Management

Ever wonder how we decide to authorize services? Our decisions are based on medical evidence and consensus of health care professionals. For more details, click here.

Grow Well™ App

Your one place to find trusted health information and connect to FirstCare resources for you and your family through every age and stage. Text “App” to 844.903.GROW (4769) or learn more here.

Helpful Links and Phone Numbers

Texas MedicaidInformation and Referral:
2-1-1 or 1-877-541-7905
Enrollment Helpline: 1-800-964-2777
TTY: 1-800-735-2989 
Texas Health Steps (THSteps)Health care for children, birth through age 20, who have Medicaid
1-877-847-8377 (1-877-THSTEPS)
MCNA Dental (Medicaid)Medicaid & CHIP dental plan for Texas
1-855-691-6262
TTY: 1-800-955-8771
DentaQuest (Medicaid)Medicaid & CHIP dental plan for Texas
1-800-516-0165
TTY: 1-800-855-2880
United DentalMedicaid & CHIP dental plan for Texas
1-877-901-7321
TTY: 711
Liberty Dental (Medicaid)Dental services for Medicaid STAR pregnant women age 21 and over
1-877-550-4374
Navitus Health SolutionsFirstCare’s Pharmacy Benefit Manager 
1-877-908-6023
TTY: 711
OCCC Financial Literacy Information1-800-538-1579

Send to a Friend

* Required field

Captcha The math problem above is intended to reduce spam.